New research shows that pregnant women who receive the mRNA vaccine against Covid 19 transmit high levels of protective antibodies to their babies.
According to Reuters, new research shows that pregnant women who receive the “mRNA” vaccine against Covid 19 transmit high levels of protective antibodies to their babies.
Doctors analyzed cord blood from 36 infants whose mothers had received at least one dose of mRNA technology vaccine. Recent studies in this area need further research to confirm the findings, but in general, the findings, published Wednesday in the American Journal of Obstetrics and Gynecology, show that antibodies that the mother makes to the vaccine cross the placenta and into the placenta. Most likely, it will be useful for the baby after birth.
“It is not yet clear whether the timing of vaccination during pregnancy is related to the amount of antibodies in the baby,” said Ashley Roman of NYU Langone Health, a New York University-affiliated medical center in New York City. “In addition, we do not know how long these antibodies remain in the baby, but the presence of these antibodies in the umbilical cord blood, which is fetal blood, indicates that the baby may also benefit from maternal vaccination.”
